evar

Can EVAR become the first choice for AAA repair ?

是否可以成为腹主动脉瘤的第一选择？

Objective : To evaluate the use of endovascular aortic repair ( EVAR ) and open aortic surgery ( IAS ) for treatment of abdominal aortic aneurysm .

目的：比较腹主动脉瘤开放手术与腔内治疗的效果。

Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm ( EVAR trial 1 ), 30-day operative mortality results : Randomised controlled trial

比较腹主动脉瘤患者接受动脉瘤腔内修复与开放式修复术的术后30d死亡率（EVAR1试验）：随机对照试验

The late durability of endovascular aneurysm repair ( EVAR ) has been limited by progressive aortic degeneration believed to be mediated by matrix metalloproteases ( MMP ) .

腔内动脉瘤修复术（EVAR）的远期疗效受到基质金属蛋白酶MMP介导的主动脉退化的限制。

With the development of medical technology , endovascular aortic repair ( EVAR ) has become the preferred treatment plan in the treatment of thoracic aortic aneurysm , the key of endovascular repair lies in the development of artificial vascular system .

随着医疗技术的发展，主动脉腔内修复技术（EVAR）已成为治疗胸主动脉瘤的首选治疗方案，而腔内修复术的关键在于人工血管系统的研制。